Want to join the conversation?
$BAX paid approx. $14MM to acquire the rights to cefazolin injection in GALAXY Container (2 g/100 mL) in 3Q15. The purchase price was capitalized as an intangible asset and $BAX is amortizing the asset over the estimated economic life. In the Other franchise, sales fell mainly due to one of $BAX's pharma partners assuming their own production.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)